Cancer Gene Therapy Market to Surpass Valuation of US$ 17.57 Billion By 2033 | Astute Analytica
International collaborations, refined gene-editing protocols, and targeted immunologic maneuvers keep the cancer gene therapy ...
ALS News Today11h
AMT-162 gene therapy trial for SOD1-ALS set for next dose group
Qure is planning soon to start enrolling patients in a second dose group as part of a clinical trial testing AMT-162 for SOD1 ...
Gene therapies have been uneven for DMD — but these companies hope to turn the tide
Despite mixed results using gene therapies to treat Duchenne muscular dystrophy, drug developers are pushing ahead with the ...
Nature3d
A new dual-vector approach to enhance recombinant adeno-associated virus-mediated gene expression through intermolecular cis activation
Based on this, we have developed a new approach to enhance the efficiency of rAAV-mediated gene expression. This approach uses co-infection with a transgene-containing vector and a second vector ...
Managed Healthcare Executive5d
Gene Therapy’s Pipeline Has a Steady Flow of More Than 2,000 Candidates
The majority are in the very early preclinical stage of development, but applications for regulatory approval have been ...
GlobalData on MSN13d
Viralgen and Axovia to develop gene therapy for retinal dystrophy
Viralgen and Axovia are set to form a partnership to progress the development and manufacturing of gene therapy for retinal ...
precisionmedicineonline9h
Fondazione Telethon Seeking Approval for Wiskott-Aldrich Syndrome Gene Therapy in Europe
Thirty patients have received the gene therapy within a clinical trial and early-access program, and the foundation also hopes to seek approval in the US.